Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Predictive and Prognostic Impact of Blood-Based Inflammatory Biomarkers in Patients with Gastroenteropancreatic Neuroendocrine Tumors Commencing Peptide Receptor Radionuclide Therapy.
Diagnostics (Basel). 2021 Mar 12;11(3):504. doi: 10.3390/diagnostics11030504.
Diagnostics (Basel). 2021.
PMID: 33809226
Free PMC article.
Assessment of γ-H2AX and 53BP1 Foci in Peripheral Blood Lymphocytes to Predict Subclinical Hematotoxicity and Response in Somatostatin Receptor-Targeted Radionuclide Therapy for Advanced Gastroenteropancreatic Neuroendocrine Tumors.
Derlin T, Bogdanova N, Ohlendorf F, Ramachandran D, Werner RA, Ross TL, Christiansen H, Bengel FM, Henkenberens C.
Derlin T, et al. Among authors: ohlendorf f.
Cancers (Basel). 2021 Mar 25;13(7):1516. doi: 10.3390/cancers13071516.
Cancers (Basel). 2021.
PMID: 33806081
Free PMC article.
Item in Clipboard
Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors.
Ohlendorf F, Henkenberens C, Brunkhorst T, Ross TL, Christiansen H, Bengel FM, Derlin T.
Ohlendorf F, et al.
Q J Nucl Med Mol Imaging. 2022 Dec;66(4):361-371. doi: 10.23736/S1824-4785.20.03238-0. Epub 2020 Apr 14.
Q J Nucl Med Mol Imaging. 2022.
PMID: 32286768
Item in Clipboard
Cite
Cite